Biogen (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Steward Partners Investment Advisory LLC lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 31.8% during the 4th quarter, according to its most recent disclosure with the ...

Biogen believes that some of its new drugs, Leqembi, Skyclarys and Zurzuvae, have the potential to revive long-term growth. Can Biogen achieve this goal?

Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAb in their systems.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Major indices closed higher on Friday in what had otherwise been a losing week for the Dow Jones. At the close, the Dow Jones ...

Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...